Blinova K, Dang Q, Millard D, Smith G, Pierson J, Guo L, Brock M, Lu HR, Kraushaar U, Zeng H, Shi H, Zhang X, Sawada K, Osada T, Kanda Y, Sekino Y, Pang L, Feaster TK, Kettenhofen R, Stockbridge N, Strauss DG, Gintant G.
Cell Rep, 2018
Summary:
Discover how Maestro MEA technology helped test human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for improving Torsades de Pointes arrhythmia risk predicition of drugs in the Comprehensive In Vitro Proarrhythmia Assay (CiPA) Initiative.
